Search results for: 'diagnostics market outlook services'

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...

This study addresses the imaging services trends and challenges seen at various global outpatient imaging sites. The focus of this study addresses various imaging services provided using modalities such as fixed and portable X-ray and ultrasound devices as well as advanced imaging equipment such as mammography, CT, MRI, C-arm, and molecular imaging...

This study examines the trends in the Latin American and the Caribbean (CALA) customer experience outsourcing (CX Outsourcing) services market and forecasts the market size. The report provides extensive coverage of services delivered in each local market and those provided from the CALA countries to others overseas. In this sense, offshore service...

21 Dec 2022  |  North America  |  Market Research

Growth Opportunities in the North American VoIP Access and SIP Trunking Services Market, Forecasts to 2028

VoIP Services Find New a New Role in Cloud PBX Integrations

Infographics

×

This study delivers market sizing, growth forecasts and market share analysis in the next-generation voice access services market comprising: • Voice over Internet Protocol (VoIP) trunking • Session Initiation Protocol (SIP) trunking • Basic VoIP access services • Cloud Calling Plans VoIP access and VoIP/SIP trunking services involve the...

23 May 2017  |  North America  |  Market Research

Growth Opportunities in the US In Vitro Diagnostics (IVD) Market, Forecast to 2021

US IVD Market Witnesses Pricing Fluctuations Due to the PAMA Regulation

Infographics

×

The In Vitro Diagnostics (IVD) landscape in the United States is extremely dynamic, with a high level of merger and acquisition activity with many high-value deals still pending. Both clinical laboratories and manufacturers are increasingly vying for smaller specialized niche technology companies to increase their market share. Molecular point of c...

19 Feb 2025  |  Global  |  Market Research

Antimicrobial Resistance Diagnostics Market, Global, 2024–2030

The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput

Infographics

×

This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to in...

The continued penetration of high-speed broadband services into advanced mobile devices, developments in the cellular machine-to-machine (M2M) and Internet of Things (IoT) markets, and the resurgence of unlimited mobile plans are the top drivers of the North American mobile services market. This tracker presents metrics for leading mobile operators...

14 Feb 2025  |  Global  |  Market Research

Proteomics Research Tools and Diagnostics Market, Global, 2024-2030

The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery

Infographics

×

In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...